Seres Therapeutics (MCRB) said Thursday it received a $50 million installment related to the sale of its VOWST business to Societe des Produits Nestle.
The company said in September that it received $175 million in gross proceeds and expects to receive two installment payments.
Seres said it expects the next installment of $25 million in July.
Current cash reserves and anticipated future deal payments are anticipated to extend the company's cash runway into Q1 2026, Seres added.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。